360 related articles for article (PubMed ID: 10580127)
1. Glycoprotein glycosylation and cancer progression.
Dennis JW; Granovsky M; Warren CE
Biochim Biophys Acta; 1999 Dec; 1473(1):21-34. PubMed ID: 10580127
[TBL] [Abstract][Full Text] [Related]
2. N-acetylglucosaminyltransferase V (Mgat5)-mediated N-glycosylation negatively regulates Th1 cytokine production by T cells.
Morgan R; Gao G; Pawling J; Dennis JW; Demetriou M; Li B
J Immunol; 2004 Dec; 173(12):7200-8. PubMed ID: 15585841
[TBL] [Abstract][Full Text] [Related]
3. Metabolic homeostasis and tissue renewal are dependent on beta1,6GlcNAc-branched N-glycans.
Cheung P; Pawling J; Partridge EA; Sukhu B; Grynpas M; Dennis JW
Glycobiology; 2007 Aug; 17(8):828-37. PubMed ID: 17483135
[TBL] [Abstract][Full Text] [Related]
4. UDP-N-acetylglucosamine:alpha-6-D-mannoside beta1,6 N-acetylglucosaminyltransferase V (Mgat5) deficient mice.
Dennis JW; Pawling J; Cheung P; Partridge E; Demetriou M
Biochim Biophys Acta; 2002 Dec; 1573(3):414-22. PubMed ID: 12417426
[TBL] [Abstract][Full Text] [Related]
5. Aberrant N-glycosylation in cancer: MGAT5 and β1,6-GlcNAc branched N-glycans as critical regulators of tumor development and progression.
de-Souza-Ferreira M; Ferreira ÉE; de-Freitas-Junior JCM
Cell Oncol (Dordr); 2023 Jun; 46(3):481-501. PubMed ID: 36689079
[TBL] [Abstract][Full Text] [Related]
6. Suppression of tumor growth and metastasis in Mgat5-deficient mice.
Granovsky M; Fata J; Pawling J; Muller WJ; Khokha R; Dennis JW
Nat Med; 2000 Mar; 6(3):306-12. PubMed ID: 10700233
[TBL] [Abstract][Full Text] [Related]
7. T cell receptor signaling co-regulates multiple Golgi genes to enhance N-glycan branching.
Chen HL; Li CF; Grigorian A; Tian W; Demetriou M
J Biol Chem; 2009 Nov; 284(47):32454-61. PubMed ID: 19706602
[TBL] [Abstract][Full Text] [Related]
8. Diverse expression of N-acetylglucosaminyltransferase V and complex-type β1,6-branched N-glycans in uveal and cutaneous melanoma cells.
Pocheć E; Rydlewska M; Przybyło M; Lityńska A
Acta Biochim Pol; 2015; 62(2):323-8. PubMed ID: 26098720
[TBL] [Abstract][Full Text] [Related]
9. Minimal catalytic domain of N-acetylglucosaminyltransferase V.
Korczak B; Le T; Elowe S; Datti A; Dennis JW
Glycobiology; 2000 Jun; 10(6):595-9. PubMed ID: 10814701
[TBL] [Abstract][Full Text] [Related]
10. Glycans and cancer: role of N-glycans in cancer biomarker, progression and metastasis, and therapeutics.
Taniguchi N; Kizuka Y
Adv Cancer Res; 2015; 126():11-51. PubMed ID: 25727145
[TBL] [Abstract][Full Text] [Related]
11. Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation.
Demetriou M; Granovsky M; Quaggin S; Dennis JW
Nature; 2001 Feb; 409(6821):733-9. PubMed ID: 11217864
[TBL] [Abstract][Full Text] [Related]
12. Galectin binding to Mgat5-modified N-glycans regulates fibronectin matrix remodeling in tumor cells.
Lagana A; Goetz JG; Cheung P; Raz A; Dennis JW; Nabi IR
Mol Cell Biol; 2006 Apr; 26(8):3181-93. PubMed ID: 16581792
[TBL] [Abstract][Full Text] [Related]
13. Antibodies that recognize bisected complex N-glycans on cell surface glycoproteins can be made in mice lacking N-acetylglucosaminyltransferase III.
Lee J; Park SH; Stanley P
Glycoconj J; 2002 Mar; 19(3):211-9. PubMed ID: 12815232
[TBL] [Abstract][Full Text] [Related]
14. Beta N-acetylglucosaminyltransferase V (Mgat5) deficiency reduces the depression-like phenotype in mice.
Soleimani L; Roder JC; Dennis JW; Lipina T
Genes Brain Behav; 2008 Apr; 7(3):334-43. PubMed ID: 17883406
[TBL] [Abstract][Full Text] [Related]
15. Complex N-glycan and metabolic control in tumor cells.
Mendelsohn R; Cheung P; Berger L; Partridge E; Lau K; Datti A; Pawling J; Dennis JW
Cancer Res; 2007 Oct; 67(20):9771-80. PubMed ID: 17942907
[TBL] [Abstract][Full Text] [Related]
16. Beta1,6-N-acetylglucosamine-bearing N-glycans in human gliomas: implications for a role in regulating invasivity.
Yamamoto H; Swoger J; Greene S; Saito T; Hurh J; Sweeley C; Leestma J; Mkrdichian E; Cerullo L; Nishikawa A; Ihara Y; Taniguchi N; Moskal JR
Cancer Res; 2000 Jan; 60(1):134-42. PubMed ID: 10646865
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of N-acetylglucosaminyltransferases III and V in human melanoma cells. Implications for MCAM N-glycosylation.
Bubka M; Link-Lenczowski P; Janik M; Pocheć E; Lityńska A
Biochimie; 2014 Aug; 103():37-49. PubMed ID: 24726881
[TBL] [Abstract][Full Text] [Related]
18. Radiosensitisation of human glioma cells by inhibition of β1,6-GlcNAc branched N-glycans.
Shen L; Dong XX; Wu JB; Qiu L; Duan QW; Luo ZG
Tumour Biol; 2016 Apr; 37(4):4909-18. PubMed ID: 26526581
[TBL] [Abstract][Full Text] [Related]
19. Reduced hepatocyte proliferation is the basis of retarded liver tumor progression and liver regeneration in mice lacking N-acetylglucosaminyltransferase III.
Yang X; Tang J; Rogler CE; Stanley P
Cancer Res; 2003 Nov; 63(22):7753-9. PubMed ID: 14633700
[TBL] [Abstract][Full Text] [Related]
20. Reduced contact-inhibition and substratum adhesion in epithelial cells expressing GlcNAc-transferase V.
Demetriou M; Nabi IR; Coppolino M; Dedhar S; Dennis JW
J Cell Biol; 1995 Jul; 130(2):383-92. PubMed ID: 7615638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
